In 2024, the forecasted standardized mortality rate for malignant neoplasms among men in Japan is 225.8 per 100,000. This rate is projected to decrease annually, reaching 212.0 by 2028. Compared to 2023, the data shows a consistent decline through these years. The year-on-year percentage decrease lies around 1.5% to 1.6%, with a predicted Compound Annual Growth Rate (CAGR) of approximately -1.6% for these years. This trend signifies a steady reduction in male cancer mortality rates.
Future trends to watch for include advancements in medical technologies, early detection practices, lifestyle changes, and public health initiatives in Japan, which could further influence mortality rates and accelerate the declining trend.
